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Abstract.  We demonstrate that the alternatively 
spliced variable (V) region of fibronectin (FN) is re- 
quired for secretion of FN dimers during biosynthesis. 
Alternative splicing of the V  segment of the rat FN 
transcript generates three subunit variants (V120,  V95, 
V0) that differ by the inclusion or omission of an addi- 
tional  120 or 95 amino acids.  We are exploring the 
functions of this segment by expressing variant cDNAs 
in normal and transformed fibroblasts. Like FN itself, 
the cDNA-encoded polypeptides (deminectins [DNs]) 
containing the V120 or V95 segment are efficiently 
secreted as disulfide-bonded homodimers.  However, 
few homodimers of DNs lacking this region,  V0 DNs, 
are secreted.  V0 homodimers do form inside the cell, 
as demonstrated by biosynthetic analyses of dimer for- 
mation and secretion using pulse-chase and time 
course experiments, but these dimers seldom reach the 
cell surface and are probably degraded intracellularly. 
Coexpression of V0 and V120 subunits results in intra- 
cellular formation of three types of dimers, V0-V0, V0- 
V120,  and V120-V120,  but only the V120-containing 
dimers are secreted.  This selective retention of V0 
homodimers indicates that the V  region is required for 
formation and secretion of native FN dimers.  In an 
analogous in vivo situation,  we show that plasma FN 
also lacks V0-V0 dimers and consists of V0-V+ and 
V+-V+  combinations. 
Dissection of V  region sequences by deletion map- 
ping localizes the major site involved in DN dimer 
secretion to an  18-amino acid segment within V95. In 
addition,  high levels of dimer secretion can be re- 
stored by insertion of V  into a heterologous site 10 kD 
COOH terminal to its normal location.  We discuss the 
potential role of intracellular protein-protein interac- 
tions in FN dimer formation. 
F 
IBRONECTIN (FN) ~ is an integral  part of the extracel- 
lular  matrix,  binding  to cells, collagen,  proteogly- 
cans, and other macromolecules, and playing an im- 
portant role in cell adhesion and spreading,  cell migration, 
hemostasis and thrombosis, cell morphology,  and cytoskele- 
tal organization,  and oncogenic transformation  (for review, 
see Yamada,  1983; Hynes, 1986; McDonald,  1988; Ruos- 
lahti,  1988; Mosher, 1989). Alternative  splicing of the FN 
gene transcript  results in cell type specific subunit variation 
(Schwarzbauer et al.,  1983, 1985, 1987b; Kornblihtt  et ai., 
1984,  1985; Bernard et al.,  1985; Paul et al.,  1986; Seki- 
guchi et al., 1986; Norton and Hynes, 1988; Schwarzbauer, 
1989). Three sites of alternative splicing occur in FN: EIHA, 
EIIIB and the variable (V) region (also known as ED-A, 
ED-B and IIICS, respectively). The first two are single type 
III repeats encoded by single  exons  that  are included  or 
skipped during splicing and are found in a subset of cellular 
FN subunits.  Exon subdivision of the V region gives rise to 
three variants in rat and five in human by splicing within the 
coding sequences.  The three forms in rat are called V0, V95, 
and V120 to denote the number of extra amino acids included 
in each variant. 
1. Abbreviations  used in this paper: DN, demineetin; DOC, deoxycholate; 
FN, fibronectin; GSBP, glycosylation site binding protein; LTR, long termi- 
nal repeat; PDI, protein disulfide  isomerase; V, variable region of FN. 
The  requirement  for different  combinations  of alterna- 
tively spliced FN variants  in any biological processes re- 
mains obscure. In an effort to understand  the role of alterna- 
tive splicing in FN structure and function, we are expressing 
cDNAs encoding the rat FN variants  via retroviral  vectors 
in cultured mammalian  cells and analyzing  the activities  in 
a  variety of biochemical and  cell biological experiments 
(Schwarzbauer  et al.,  1987a). We have concentrated  on the 
COOH-terminal half of FN encompassing  the three regions 
of alternative  splicing,  the cell, heparin,  and fibrin binding 
domains,  and the cysteine residues required for interchain 
disulfide bond formation.  FN dimers are assembled in the 
rough endoplasmic reticulum (Choi and Hynes, 1979) and 
the truncated polypeptides (deminectins  [DNs]) are secreted 
as dimers both with the endogenous FN monomers (FN-DN 
heterodimers) and, in the case of V+ forms, with themselves 
(DN homodimers). The levels of V+ DN homodimers and 
heterodimers in the cell conditioned medium are propor- 
tional  to the amounts  of each subunit synthesized  suggest- 
ing dimer  assembly by random  assortment  of monomers 
(Schwarzbaner  et al.,  1987a).  In mouse fibroblasts,  which 
make relatively high levels of FN, the heterodimer concen- 
tration  far exceeds the DN homodimer concentration. 
We have elected to express DNs in transformed  cells that 
make much less endogenous FN resulting in V+ DN dimers 
secreted at levels in excess of FN-DN heterodimers.  How- 
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ditioned medium. This could be explained in a number of 
ways including that the V segment is somehow required ei- 
ther for dimer formation or for efficient secretion of DN 
dimers, or that the presence of the V segment confers stabil- 
ity on FN dimers. 
In this report, we describe our analyses of the involvement 
of the V  region of alternative splicing in intracellular FN 
dimer formation and secretion. V0 DN homodimers are not 
found in the cell medium, even though V0 dimers do form 
inside the cell. The truncated V0 subunits can be "rescued" 
by expressing both V0 and V120 DNs in the same cell, in 
which case VO-V120 mixed dimers are secreted. Our analy- 
ses of purified rat plasma FN demonstrate that VO homo- 
dimers are absent from this population as well. We have fur- 
ther characterized the sequences involved in this process by 
deletion mapping of the V region. From these data we dis- 
cuss FN dimer formation and secretion based on intracellu- 
lar interactions during processing and transport. 
Materials and Methods 
Cell Culture 
Ib2 and SVT2 (SV40-tmns~rmed  3'I"3  provided by A Levine lab) cell lines 
were grown in DME supplemented with 10% calf serum (Hyclone Labora- 
tories, Logan, Utah). ~b2 cells were transfected with retrovirul vectors con- 
raining various FN cDNAs and SVT2 cells were infected with recombinant 
retrovirases produced either transiently or stably by the transfected ~b2 cells 
as previously described (Schwarzbauer et al., 1987a). Transfectants and in- 
fectants were selected for resistance to either Geneticin (Gibeo Laborato- 
ties, Grand Island, NY) or histidinol (Sigma Chemical Co., St. Louis, MO) 
depending on which selectable marker, neo (Davies and Jiminez, 1980) or 
hisD (Hartman  and Mulligan,  1988), was present  in the vector. Usually 
6-12 colonies from each infection were cloned and screened for levels of 
eDNA-encoded  polypeptide  production.  To produce  cells secreting  two 
different DNs, cells were first infected with one recombinant  virus and 
selected  for drug resistance  followed  by infection  with the second recom- 
binant  virus  and cloned after  selection  for double resistance. 
FN and Antibody Preparation 
FN was purified from rat plasma by gelatin-Affigel affinity chromatography 
(Engvall and Ruoslahti, 1977). For preparation of anti-FN antisera,  FN was 
further purified by ion exchange chromatography using a Mono Q HR5-5 
column (Pharmaeia  Fine Chemicals,  Piscatewny, NJ; LKB Instruments 
Inc., Bromma, Sweden) with an LKB HPLC system. FN was applied to the 
column in 20 mM Ttis-HCl, pH 8.3, 50 mM NaCl, and eiuted at ,,o0.25 M 
NaCl in a linear gradient of .05-1.0 M NaCI. 
New Zealand white rabbits were immunized with 0.1 nag Of FN in com- 
plete Freund's adjuvant (Gibco Laboratories) and boosted after 2 wk with 
another  0.1 mg in incomplete Freund's  (Mautner  and Hynes,  1977). Irn- 
rnune bleeds  were collected weekly beginning 2 wk after the boost.  In- 
dividual bleeds of similar titer were pooled for use in immunoprecipitations 
and immunoblotting. The amount of antiserum needed to immunoprecipi- 
tare all FN from a given quantity of cell conditioned  medium was deter- 
mined empirically  and all immunopreeipitations  were carried out in anti- 
body excess. 
Metabolic Labeling and Immunoprecipitations 
Cells were metabolically  labeled with [3SS]methionine (trans-labei,  ICN 
Radiochemicals, Irvine, CA) at 25/~Ci/ml for 24 h. Labeled media were 
collected, cells and debris were removed by centrifugation,  and EDTA and 
PMSF were added to 10 and 2 raM, respectively, as protease inhibitors. 
Short  term labelings  were performed  as described  by Choi and  Hynes 
(1979). For determination of  the rate of secretion Of  FN and DNs, cells were 
labeled continuously with 200 ~Ci [3SS]methionine/ml of medium and ali- 
quots were removed at selected time points and processed as above but with 
two additional inhibitors, iodoacetic acid and N-ethylmaleimide at 1 mM 
each. In pulse-chase  experiments,  monolayers were pulsed with methio- 
nine-free  medium containing  200 t~Ci  [35S]methionlneJml  for I0 mill  fol- 
lowed  by a chase with medium plus  excess  cold  methionine for  times  from 
10 to 60 rain. Cells were rinsed with PBS followed by lysis with cold 2% 
deoxycholate (DOC) in 50 mM Tris-HCl, pH 8.8, 2 mM EDTA, plus inhibi- 
tots as above. Cell lysates were put through a 26G hypodermic needle at- 
tached to a  1-cm  3 syringe to shear  DNA and  spun to remove DOC in- 
solubles. 
3SS-labeled FN and DNs were irnmunopreeipitated in the presence  of 
0.5% NP40/0.5% Doe/0.1% SDS using a rabbit anti-rat pFN polyelonal 
antiserum  followed by Protein  A-agarose beads  (Repligen Corp.,  Cam- 
bridge,  MA). Beads were washed and proteins were eiuted by boillns in 
electrophoresis sample buffer without reducing agent, tmmunopreeipitation 
of 0.1 ~tg of purified rat pFN with anti-V95 antiserum was carried out as de- 
scribed above. However, the antibody titer was insufficient to bring down 
all of the FN, so an aliquot of the supernatant was taken through two more 
rounds of immunopreeipitation by addition of more anti-V95 and Protein A 
beads. 
In some cases, FN" and DNs were partially purified  from conditioned 
medium by batohwise heparin-agarose (Sigma Chemical Co.) affinity chro- 
matography, washed with PBS, and eiuted as for immunoprecipitations. 
Polyacrylamide Gel Electrophoresis and 
Immunoblotting 
Protein samples with or without reduction were electrophoresed along side 
prestained molecular weight standards (Sigma Chemical Co.) through SDS 
polyacrylamide gels (Laemmli,  1970), fixed, treated with Enhance (New 
England Nuclear, Boston, MA), and exposed to film (X-omat; Eastman Ko- 
dak Co., Rochester, NY) at -80"C for 1211-3 wk depending on the experi- 
ment.  For analysis  by two-dimensional  gel eiectmphoresis,  nonreduced 
samples were run in SDS-5 % polyacrylamide  tube gels, reduced in situ 
with 10% fl-mercaptoethanol, and electrophoresed through SDS-6% poly- 
acrylamide  gels.  Unlabeled  sampies  were  visualized  by  silver staining 
(Merril et al., t984). 
Fluorographic  signals from one dimensional  gels were quantitatad by 
densitometry using a video densitometer (620; Bio-Rad Laboratories, Cam- 
bridge, MA). Alternatively, bands were cut out of dried, Enhanced gels and 
counted in  Ecoscint  (National  Diagnostics,  Inc.,  Somerville,  NJ)  in  a scin- 
tillation  counter  (Packard Instrument  Co., Inc.,  Downers Grove, IL). 
For  antibody  detection  after  electrophoresis,  proteins  were  transferred  to 
nitrocellulose  (Schleicher  &  Schuell,  Inc, Keene, NH) using  the Mini- 
Protean  II  transfer  apparatus  (Bio-Rad Laboratories,  Cambridge, MA) and 
following the protocol suggested by the manufacturer. Filters were blocked 
and probed  with antibodies as described  by Pa~ et al. 0986) using an 
anti-rat pFN polyclonal antiserum at a dilution of 1:500. Bound antibody 
was detected using  biotinylated  goat anti-rabbit  second antibody,  strep- 
tavidin horseradish  peroxidase,  and 4-CN substrate  (Bethesda Research 
Laboratories,  Gaithersburg,  MD). 
Retroviral Vectors  and cDNA Constructions 
and Deletions 
The retroviral vector, pLP, used throughout these studies is a modification 
of pDOP (Schwarzbaner et al., 1987a) in which the pBR322 origin of repli- 
cation has been moved to the 3' end of the neo gene, the retroviral 5' splice 
site has been deleted, and the pBR322 plasmid backbone has been deleted 
leaving only polyoma early region sequences outside of the long terminal 
repeats (LTRs). Two forms of pLP have been constructed that differ only 
in the encoded preJpro sequence: pLPP with the parathyroid hormone sig- 
nal sequence eDNA preceding the cloning site and pLPS with FN eDNA 
encoding the signal sequence plus the first 18 amino acids of mature FN. 
Both of these vectors were used in the expression experiments but only data 
from pLPS constructions are presented.  The rat FN cDNAs that were in- 
serted into pLPS had their 5' termini in the middle of type HI-8 ~ig. 1 A) 
and extended to the COOH terminus. All were minus EIIIA and plus or mi- 
nus the V region as indicate. 
Some of the experiments required coexpression of two different cDNAs. 
To obtain retrovirally infected cells carrying two different proviruses, a sec- 
ond selectable marker  was used, the bacterial his D gene (Harmmn and 
Mulligan,  1988). The vector, pGEP-His, was constructed by replacing the 
neo-pBR322 origin cassette in pLPP with the his D gene. For propagation 
in bacteria, the polyoma early region sequences outside of the LTRs were 
substituted with the amp gene and origin of replication  sequences from 
pGEM (Promega Biotec, Madison,  WI). 
The Journal of Cell Biology, Volume 109, 1989  3446 Figure L A, Schematic of  the domain structure of FN and DNs. The domains for binding to fibrin, collagen, cells, and heparin are labeled. 
A pair of COOH-terminal cysteines form the interchain disulfides (SS) in the dimer. The two sites of alternative splicing, EIIIB and EIHA 
(thick bars, B and A, respectively), are located on either side of the cell binding region. Between the collagen domain and EHIB are type 
HI repeats 1-7. The amino-termini of V0 and V120 DNs lie in the middle of type III-8, immediately COOH-terminal to EIIIB. These DNs 
span the COOH-terminal half of FN, and are EIIIA minus and V120 plus or minus (l,O) as indicated. B, Analysis of secreted DNs. FN 
and DN were purified from labeled media of SVT2 infectants by batchwise heparin-agarose affinity chromatography and electrophoresed 
reduced to separate monomers or nonreduced for dimers. Identities of FN and DNs were confirmed by immunoprecipitation (not shown). 
(Reduced) FN, V120, and VU DN monomers are indicated as are the V0-SS pol~des  (*) that lack the COOH-terminal interchain 
disulfides and are secreted as monomers. V120 DNs migrate as a diffuse band at '~120 kD and VD DNs appear as a doublet between 100 
and 110 kD. (Nonreduced) VI20 homodimer levels (DN-DN) exceed heterodimers (FN-DN) while only the heterodimer form is present 
in the VO sample. The position where "vD DN homodimers would be located, if present,  is marked (arrow). Prestained molecular mass 
standards of 180, 116, 84, 58, and 48 kD were included on all gels (not shown). 
All deletions within the V segment and of the COOH-terminai cysteincs 
were made by using conveniently  located restriction  endonnclease  sites. En- 
zymes were  from  New  England Biolabs (Beverly,  MA) or Boehringer 
Mannheim Diagnostics, Inc. (Houston, TX). The region encoding the cys- 
teines involved in interchain disulfide bonding was removed by cutting the 
mt FN cDNA with Arc I (at position 7330) and Nla HI (7390), the ends 
were blunted with Klenow fragment of F~cherichia coil DNA polymerase, 
and religated to delete a 20-amino acid piece. Sites within and adjacent to 
the V segment that were used to create deletions include Bgl H (at position 
56 within the 360 bases of V), San3A I (176), Nla HI (192), Fnu4H I (220), 
Hae HI (240), Acc I (308), Him II (333), and Alu 13'ofV (369).  Deletions 
called 18, 20J,  39,  40,  and 93 spanned regions from 192-240,  308-369, 
220-333, 56-176, and 56-333, ~pectively. To insert the V region into a 
heterologons site,  a fragment from a BstE II site at position 18 to Hpa II 
at 333 was ligated into eDNA linearizad with Hinc lI and Stu I which cut 
between sequences encoding type HI-15 and type 1-10  (Schwarzbaner et al., 
1983). All deletions were characterized by restriction mapping and in most 
cases by subcloning into one of the pGEM vectors (Promega Biotec) and 
sequencing across the junctions using Sequenase (United States Biochemi- 
cal Corp., Cleveland, OH). 
Results 
Dimer Formation by VO and V120 Subunit Variants 
The FN domain structure and the truncated DNs are illus- 
trated in Fig. 1 A. DN cDNAs encode the rat FN signal and 
pro sequences and the first 18 amino acids of  the mature pro- 
rein connected to the COOH-terminal half of FN from the 
middle of type HI-8 to the end. The cDNAs were inserted 
into a  retroviral vector, pLPS, and transfected into the ~b2 
packaging  cell  line  to  produce recombinant  retroviruses. 
These viruses were then used to infect SVT2 cells (SV40- 
transformed 3'1"3 cells) and infected, G418-resistant clones 
were screened for high level production of DNs.  The ex- 
pressed polypeptides span the domains for binding to cells, 
heparin,  and  fibrin,  two  regions  of alternative  splicing, 
EIHA  and  V,  and  the  cysteines necessary  for interchain 
disulfide bond formation. These DNs possess many of the 
functions inherent in FN such as heparin binding activity 
(Fig. 1 B), cell attachment activity (our unpublished obser- 
vations), and disulfide-bonded dimer formation both with 
themselves (DN homodimers) and with the endogenous FN 
monomers  produced  by  the  cells  expressing  the  cDNAs 
(FN-DN heterodimers). The heterodimers are incorporated 
into the extracellular matrix (Schwarzbauer et al.,  1987a). 
When VI20 cDNAs are expressed in SV12 cells, which 
make very little of their own FN, the DN levels exceed en- 
dogenous FN levels and the DN homodimers predominate 
in the cell conditioned medium (Fig. 1 B). "vD DNs can also 
be seen in reduced samples where dimers are separated into 
monomer components, although at molar levels less than 
that of the endogenous FN (Fig. 1 B, Reduced). Also shown 
are ~)-SS DNs that are secreted as monomers because of  de- 
letion  of the  cysteines that  form  the  interchain  disulfide 
bonds (see below).  The comparison of dimer forms from 
V120- and V0-secreting cells emphasizes the disproportion- 
ately small quantities or, in many cases, complete lack of V0 
DN homodimers, although V0 DNs are secreted as heterodi- 
mers (Fig.  1 B, Nonreduced). 
Biosynthesis of  FN Dimers 
The lack of V0 homodimers in culture medium raises the 
question, are V0 DNs able to form dimers with each other? 
To answer this, we carried out pulse-chase labeling experi- 
ments and isolated the intracellular FN and DN dimers by 
immunoprecipitation. Fig. 2 shows the fluorographs of two 
dimensional nonreduced/reduced SDS-polyacrylamide gels 
of the DOC-soluble fraction of pulse-labeled cells. After a 
10-rain pulse and a  10-min chase period, FN-DN heterodi- 
mers are present in all cells. More importantly, homodimers 
of ~  DNs occur at relatively high levels (A). In cells simul- 
taneously  expressing both  VD and  V120  DNs  (B),  spots 
representing V120 homodimers, V0-V120 mixed dimers, and 
Schwarzbauer et al. Secretion of Fib*onectin Varmints  3447 Figure 2. Intraeellular dimers. Cells were pulse labeled with [35S]- 
methionine for 10 rain followed by a 10-min chase, lysed in DOC 
buffer, and immunoprecipitated as described in the Materials and 
Methods.  Immunoprecipitates from VU (A), V0+V120 (B), and 
VI20 (C) cells were electmphoresed nonreduced in the first dimen- 
sion and reduced through the  second dimension gel to separate 
dimer subunits. DNs from heterodimers (arrows)  and homodimers 
(arrowheads) are present in all three samples. VI20 and V0 DNs 
are indicated by ticks at the left (B). Subunits corresponding to 
V0-VI20 mixed dimers can be seen in the sample from double in- 
fectants (B). Immunoprecipitates of DOC lysates usually conlained 
nonspecifically associated proteins  which  form the  diagonal  in 
these fluorographs. 
V0 homodimers are clearly evident. Note the abundance of 
the intracellular VU DN dimers.  Clearly, V0  subunits are 
competent to form dimers with each other. However, these 
dimers do not appear as stable forms of DN in the condi- 
tioned medium of cells. What is their fate? 
To eliminate the possibility that the dimers are secreted but 
rapidly degraded, we carried out a time course analysis of 
secreted DNs.  Cells were labeled continuously with [35S]- 
methionine and aliquots of medium were collected and ana- 
lyzed at times from 30 rain to ~. h.  The time course data 
showed that the V0 dimers seen inside the cell in the pulse- 
chase experiments never appear at the cell surface, while 
V120 dimers begin to appear in the medium after •40  min 
of labeling, at approximately the same time as FN dimers 
(data not shown). Taken together we conclude that the V0 
dimers form inside the cell, probably within the rough en- 
doplasmic reticulum, but for some reason they are not se- 
creted and are probably degraded intracellularly. 
We next tested whether the V  segment is needed simply 
for intracellular transport to the cell surface, cDNAs encod- 
ing DNs unable to form disulfide-bonded dimers were con- 
structed by deleting the region encoding the two COOH- 
terminal cysteines and were expressed in combination with 
V0 or V120 inserts (V0-SS and V120-SS). The cell-condi- 
tioned media were screened by heparin affinity chromatogra- 
phyand  by  immunoprecipitation  for the  presence of DN 
monomers  in  nonreduced  samples.  Both  V0-SS  and 
V120"SS DNs were secreted in monomeric form and were 
stable at least for the 24-h labeling period. An example of 
a  secreted monomeric  V0-SS  DN  is  shown  in  Fig.  1 B 
(V120-SS data not shown). These results demonstrate that 
the V segment is not essential for transport of DNs from the 
ER through the Golgi complex and to the surface, and that 
the V  region is  not required to stabilize DNs  in the cell- 
conditioned medium. The fact that monomeric V0 subunits 
are secreted but V0 dimers are not shows that the selective 
retention of V0 homodimers is specific to the dimer form 
itself. 
VO-V120 Mixed Dimers Are Secreted 
When V0 DNs are dimerized with full length FN subunits, 
they are efficiently secreted. We tested the ability of V120 
DNs to replace intact FN monomers in this capacity. Cell 
clones already secreting V0 DN-FN heterodimers were in- 
fected with recombinant retroviruses carrying the V120+ 
cDNA and  the bacterial his D  gene as  selectable marker 
(Hartman and Mulligan, 1988) and infectants were identified 
by growth in double selective medium, screened for expres- 
sion of both V0 and V120 DNs, and analyzed for the types 
of dimers that were secreted. Fig. 3 A shows that doubly in- 
fected clones secrete two sizes of DN dimers,  one minor 
form that comigrates with V120 homodimers and the other 
more abundant form migrating ahead and consisting of U0- 
VI20 mixed dimers (see below). Heterodimer bands are also 
apparent in V120 and M[I+VI20 lanes but the V0 DN-FN 
band is barely visible in the parent V0 sample.  The exact 
composition of these bands was determined by two dimen- 
sional nonreduced/reduced SDS-PAGE (Fig. 3 B) and clear- 
ly demonstrates the presence of V0-V120 mixed dimers and 
the complete absence of V0 homodimers in the culture medi- 
um. In the pulse-chase analysis (Fig. 2 B), the levels of V0 
dimers within the cell are apparently reduced when V120 
and V0 forms are synthesized concomitantly suggesting that 
the V120 form is titrating out the V0 DNs and thus effectively 
decreasing the levels of V0 dimers made. Therefore, V0 DNs 
can dimerize with other truncated molecules and while these 
mixed dimers are efficiently  secreted, the V0 homodimers re- 
main inside the cells. 
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their ability to be transported through the secretory pathway. 
We examined whether the same results were obtained with 
longer DNs.  Polypeptides extending from type I1-2 (in the 
collagen domain) and from type Ill-2 to the COOH terminus 
(see Fig.  1 A), m210- and 180-kD, respectively, behaved in 
the  same manner as the  shorter DNs remaining unable to 
form secretable homodimers (data not shown). 
Analysis of Rat Plasma FN Dimers 
Rat plasma FN  (pFN)  is composed of •40%  V0 subunits 
(Schwarzbauer  et  al.,  1985).  Random  assortment  of FN 
monomers in hepatocytes, the site of synthesis of pFN (Tam- 
kun and Hynes,  1983),  would result in  16%  of the dimers 
being V0-V0, a quantity that should be easily detected if pres- 
ent.  To determine whether V0 homodimers exist in blood, 
two approaches were used to analyze the pFN dimer reper- 
toire.  First,  we immunoprecipitated pFN with an anti-V95 
antibody (Schwarzbauer et al.,  1985) and analyzed the pre- 
cipitate and the supernatant by SDS-PAGE and immunoblot- 
ring with an anti-FN polyclonal antiserum. Any dimers com- 
pletely lacking V+ subunits, namely, V0 homodimers, would 
not be precipitated by this antibody. The antibody titer was 
insufficient to completely immunoprecipitate mass amounts 
of unlabeled pFN, but, after three rounds,  we could detect 
no pFN remaining in the  supernatant (Fig.  4  A).  Further- 
more, each immunoprecipitate contained both V+  and V0 
subunits.  Therefore,  the  vast majority of V0  subunits  are 
apparently dimerized with V+  subunits.  In the second ap- 
proach, the dimers were separated into their components by 
two-dimensional  nonreduced/reduced  SDS-PAGE.  V0-V0 
dimers should migrate slightly ahead of V0-V+ and V+-V+ 
forms in the first dimension. Visualization of subunits by sil- 
ver staining  showed  no evidence of a  leading  edge of V0 
monomers indicative of V0 homodimers (Fig.  4  B).  How- 
ever, obvious trailing of the V+  spot indicates the presence 
of V+-V+ dimers. Clearly, the full spectrum of FN dimers 
that can be formed intracellularly is not represented in plas- 
ma. We conclude that rat pFN consists primarily of heterodi- 
mers of one V+  and one V0 subunit. 
Is There a Signal Sequence for Dimer Secretion? 
As  the  V  segment is  needed  for proper dimer formation/ 
secretion of FN, one might expect to find sequences within 
V that confer the ability to form secretable dimers. To define 
such  sequences,  deletion  analyses  of the  V  segment  and 
flanking regions were carried out (Fig. 5 A). The naturally 
occurring "995 alternatively spliced product has been previ- 
ously shown to form dimers comparable to V120 subunits. 
Comparison of rat, human,  and chicken sequences showed 
Figure 3.  Secreted dimers. A, Immunoprecipitates  of conditioned 
medium  from cells secreting either  V0, V120, or V0+VI20 DNs 
were electrophoresed  nonreduced  to separate dimers.  FN dimers 
(FN-FN) are visible in all lanes.  Some FN monomers,  probably 
resulting from degradation of dimers at the COOH terminus,  can 
be seen in the uninfected control sample (Un), the V0 cell line (V0), 
and migrating just behind the DN dimers in adjacent lanes (arrow- 
head). Heterodimers (FN-DN) are obvious in VI20 and V0+V120 
samples but are barely visible in the V0 cell line that was used to 
generate the V0+V120 line. DN dimers (DN-DN, upper line) are 
the predominant  dimers in the two VI20 samples.  The V0+V120 
sample  contains  a  faster  migrating,  more  abundant  species 
(DN-DN, lower line) consisting of V0-V120 mixed dimers (see be- 
low).  B,  Dimer components  were  identified by two-dimensional 
nonreduced/reduced  SDS-PAGE. V0 cells  secrete only heterodi- 
mers  (arrowhead, top). Some  heterodimers,  but  mostly  V120 
homodimers and V0-V120 mixed dimers (upper and lower arrows, 
respectively), are present in the V0+V120 medium (bottom). Posi- 
tions of V120 and V0 DNs are indicated by ticks. Note the absence 
of any V0 homodimers  in both samples. 
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DN-DN/FN-DN 
V120  2.3  ±  0.2 
V0  0.3  ±  0.3 
A20J  3.9  ±  0.6 
A40  1.4  ±  0.1 
A39  1.2  ±  0.3 
A18  0.8  ±  0.3 
A93  0.5  +  0,1 
Insert V120  2.9  ± 0.6 
Quantitation of dimer levels, Relative amounts of homodimers to heterodimers 
(DN-DN/FN-DN) were determined by scanning densitometry of fluorographs 
and by counting bands excised from gels. Ratios for at least three different 
clones were averaged and are listed with the standard deviation. Reductions in 
DN homodimer levels result in a decrease in the ratio;  this is most marked 
for A93. 
Figure 4. Purified rat pFN dimers. A, Rat pFN was immunoprecipi- 
tated with anti-V95 antiserum,  components of the first and second 
precipitates (3 and 2) and the final supernatant (Lane 1) were sepa- 
rated by 6% SDS-PAGE, transferred to nitrocellulose and immuno- 
blotted with anti-pFN antiserum.  No pFN was detected in the su- 
pernatant  after immunoprecipitation  with the anti-V antibody. B, 
Rat pFN was analyzed  by two-dimensional  nonreduced/reduced 
SDS-PAGE. Dimers  were reduced  and V0 and V120 monomers 
were separated in the second dimension (dots). No leading edge of 
V0 subunits indicative of V0-V0 dimers can be seen (arrowhead). 
a  region  in the middle of V  with the highest homologous 
stretch  (Norton and  Hynes,  1988).  Deletion  of 40  amino 
acids  (A40)  containing  this  segment had only a  moderate 
effect on the levels of DN dimers secreted (Table I). Alterna- 
tively,  one  major difference  between  forms  carrying  and 
lacking V is the presence of the COOH-terminal junction be- 
tween the V segment and the last type 111-15. Deletion of this 
region (A20J) had no negative effect on the dimers secreted 
(Fig.  5 B, Table I). 
The levels of DN homodimers and FN-DN heterodimers 
in V120,  V0, and deletion samples were quantitated and the 
average ratios of homodimer to heterodimer (DN-DN/FN- 
DN) are listed in Table I. V0-producing cell clones secreted 
V0 dimers at levels eightfold lower than parallel V120-ex- 
pressing cells. Deletion of a large part of V95, A93, resulted 
in a  significant drop in the secreted DN homodimer levels 
(Fig. 5), similar to the levels secreted by V0 cells (Table I). 
Removing smaller stretches of these 93 amino acids also re- 
duced the levels of dimers: A39 had a moderate effect while 
deleting the central  18 amino acids surprisingly caused the 
largest reduction in secreted homodimers (Fig.  5, Table I). 
So by dissection of the  V95  segment,  the major effect on 
homodimer levels is localized to an 18-amino acid site indi- 
cating that these residues play an important role in FN dimer 
formation/secretion but also suggesting that cooperative ef- 
fects of more than one segment of the V region are involved 
in this process. 
We also tested the ability of the V region to exert its effects 
from another location.  A  117 amino acid segment inserted 
between type 111-15 and type 1-10 in a V0 DN (i.e.,  10 kD 
COOH-terminal to the  normal location) totally  restored a 
high level of secreted dimers that in most cases exceeded the 
level of V120 dimers (Fig. 5, Table I). Clearly, the effects of 
V on FN dimer formation are to some extent independent of 
location within the sequence. 
Figure 5. Deletion mapping of the V segment. A, This diagram illustrates V120 (top) and the locations of the different deletions (dashed 
lines) made within the V region. All are internal deletions with the exception of A20J that spans the junction between V and type 111-15. 
VI20 is at the top; cross-hatching defines the V95 section of VI20.  O and N mark the sites of O- and N-linked glycosylation identified 
in bovine pFN. S denotes tyrosine sulfation. B, Deletions were made in the V region eDNA, mutant DNs were expressed, and secreted 
dimers were separated by SDS-PAGE. Relative amounts of FN-DN heterodimers and DN-DN homodimers can be seen for A20J, A18, 
A93, A39, and Insert-V. Samples are from different experiments and are aligned via the heterodimer bands. Some samples also contain 
slight amounts of FN monomer. 
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Multiple forms of FN arise by alternative splicing of the pri- 
mary transcript at three sites. One of these sites, the complex 
V region, exists in three forms in rat, V0, V95, or V120. In 
this report, we have demonstrated that the presence of the V 
region in at least one subunit is required for secretion of FN 
dimers.  V+  DNs  are efficiently secreted as homodimers, 
while V0 DNs transit the secretory pathway as dimers only 
when  coupled  with  a  V+  DN  or  FN  subunit.  The  V0 
homodimers that form during FN biosynthesis are retained 
inside the cell. Monomeric V0 DNs are secreted and stable 
in the cell culture medium ruling out a requirement for the 
V region in intracellular transport or extracellular stability 
and suggesting that V0 homodimers themselves are defective. 
FN monomers are disulfide-bonded into dimers in the lu- 
men of the ER  shortly after synthesis (Choi and Hynes, 
1979).  Assembly of dimers containing V+  subunits occurs 
by random assortment of monomers (Schwarzbauer et al., 
1987a).  Dimers are then transported through the Golgi ap- 
paratus and on to the cell surface. Posttranslational process- 
ing, transport, and secretion of  V0-V120 and V120-V120 DN 
dimers occur at a  rate similar to that of endogenous FN. 
However,  analysis of the biosynthesis of V0 DNs by pulse 
labeling the cells and chasing for varying times demonstrates 
that V0 DN dimers are indeed formed inside the cell, but that 
these dimers never appear at the cell surface. In fact, the lev- 
els of intracellular V0 homodimers exceed that of heterodi- 
mers and would be readily observable in the cell conditioned 
medium if present. Longer V0 DNs display the same lack of 
secreted  homodimers,  excluding the  amino terminal half 
of FN as playing a major role in dimer formation. In addi- 
tion, effects of pre/pro sequence processing are ruled out as 
two different signal sequences,  from parathyroid hormone 
(Hellerman et al.,  1984) and FN (Patel et al.,  1987),  gave 
identical results. 
The relative proportions of alternatively spliced FN sub- 
units vary in a cell type-specific manner. For example, fibro- 
blasts synthesizing cellular FN make very few if any V0 
subunits, while up to 50% of pFN subunits are V0, depend- 
ing on the species (Schwarzbauer et al.,  1985;  Paul et al., 
1986). With 40% V0 and 60% V+ subunits in rat pFN, the 
calculated percentages of FN dimers are 16% V0-V0, 48% 
V0-V+, and 36% V+-V+. However,  two experiments sug- 
gest that the V0 homodimer species is not present in purified 
pFN: separation of dimers by two dimensional nonreduced/ 
reduced SDS-PAGE and immunoprecipitation of all detect- 
able pFN dimers with an anti-V segment antibody. If plasma 
contains any V0 FN dimers, their levels are so low as to be 
undetectable by these assays. Therefore, pFN must consist 
entirely of dimers containing at least one V+ subunit in the 
proportions 80% V0-V+  and 20% V+-V+. 
The data for pFN are consistent with our results with cells 
synthesizing both V0 and V120 DNs. Three species of DN 
dimers (V0-V0, V0-V120, and V120-V120) are assembled in- 
tracellularly. Their relative proportions show that no single 
form is favored and suggest random assortment of monomers 
into dimers (see Fig. 2 B). However,  only V0-V120 mixed 
dimers and V120 homodimers are secreted. V0 homodimers 
are selectively retained by the cell and are not found in the 
cell medium. 
We carried out deletion mapping of the V segment to local- 
ize any specific sequences involved in dimer formation/se- 
cretion. Although removal of a  large part of V, 93 amino 
acids, had a  major effect on the level  of DN homodimers 
secreted, shorter deletions from within the V95 region also 
decreased the efficiency of secretion. In fact, the shortest de- 
letion tested, A18, caused a significant reduction in secreted 
homodimers. Flanking deletions of 40 and 39 amino acids 
had lesser but reproducible effects. Together the deletion data 
suggest that the central 18-amino acid portion is required for 
efficient secretion of FN  dimers but probably cooperates 
with other segments within the V95 to allow maximum se- 
cretion. Interestingly, while the 18-residue  segment would 
be present in all V+ subunits of human FN, the A39 over- 
laps considerably with the COOH terminal 31 amino acids 
omitted from one alternatively spliced form of  the human FN 
transcript  (Kornblihtt et  al.,  1984).  Using  an  antiserum 
directed against these 31 amino acids, Sekiguchi and Titani 
(1989) have recently shown that V+ subunits containing and 
lacking this segment are present in human pFN. Determina- 
tion of the combinations of variants comprising human pFN 
dimers may shed some light on the role of this region. 
One important result that proves a functional role for the 
V segment is its ability to reverse completely the V0 pheno- 
type to that of V120 dimers when inserted 10 kD carboxy ter- 
minal to its normal location.  The two locations are very 
different structurally in that the normal site is between the 
last two type III repeats (1II-14 and 111-15) each of,'-,90 amino 
acids, while the heterologous site lies between the last type 
III unit and type 1-10, a finger structure of half the size folded 
via a pair of intrachain disulfides (Petersen et al., 1983). Ap- 
parently, local information from adjacent repeats is not es- 
sential to this activity of the V region. In fact, the V-insert 
DN dimer levels were generally higher than those of V120 
dimers. 
Aside from the additional amino acids, one major differ- 
ence between V+ and V0 subunits is the presence of post- 
translational modifications.  Within the  V  segment itself, 
there  are  three  different modifications:  one  asparagine- 
linked oligosaccharide at the COOH terminus (position 117), 
one or several threonine-linked sugars around residue 73 
(Skorstengaard et al., 1986),  and a sulfate group on a tyro- 
sine located between residues 80 and 110, most probably on 
tyrosine 105 (Paul and Hynes, 1984; Huttner and Baeuerle, 
1988)  (Fig.  5  A).  V0  DNs  lacking the  carboxy terminal 
cysteines and, therefore, unable to form disulfide-bonded di- 
mers, were efficiently secreted and accumulated in the cul- 
ture medium as monomers showing that modifications with- 
in the V segment, and the V segment itself, are not essential 
for synthesis and secretion. Although A18 contains the site(s) 
of 0-1inked  glycosylation identified in bovine pFN,  other 
sites may exist in cFN and the diffuse appearance of the 
fluorographic bands from these subunits suggests that they 
retain a large degree of modification. Taken together, there 
is no apparent correlation between the deletion data and the 
presence  or absence  of specific  sites  of posttranslational 
modification. 
Many studies  of protein  biosynthesis,  oligomerization, 
processing, and transport to the cell surface have been car- 
fled out with viral membrane glycoproteins, namely, VSV-G 
protein and influenza hemagglutinin. While normal forms of 
these proteins are modified, processed and transported quite 
efficiently, mutant proteins exist that cannot exit the rough 
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Gething et al., 1986; Copeland et al., 1986, 1988). A similar 
phenomenon has been observed for the cellular proteins, im- 
munoglobulins (Morrison and Scharff,  1975; Bole et al., 
1986) and silk fibroin (Takei et al., 1984). Immunoglobulin 
heavy  chains,  when  synthesized in  the  absence  of light 
chains, are not secreted and persist in the ER in association 
with BiP (Bole et al., 1986). Some elegant studies using anti- 
bodies that distinguish native and nonnative conformations 
of hernagglutinin have shown that these mutants are deficient 
in their ability to oligomerize properly and consequently 
maintain an unfolded conformation which inhibits their move- 
ment along the pathway and results in intracellular degrada- 
tion (Copeland et al., 1986; Gething et al., 1986). Although 
FN is "free" in the lumen of the ER as opposed to membrane- 
bound, it seems likely that these conclusions could apply to 
our results as well. Possibly V0 dimers are in some way mis- 
folded and therefore cannot proceed along the normal secre- 
tory pathway. However, V0 DNs can traverse the pathway ei- 
ther as monomers or as members of heterodimers suggesting 
that something inherent in the V0 homodimers makes them 
conformationally defective. 
The monomer orientation in bovine pFN dimers is reported 
to be antiparallel (Skorstengaard et al.,  1986).  That is, al- 
though the subunit sequences in the COOH terminus are 
identical, opposite cysteine residues disulfide  bond with each 
other. From this, one possible explanation for misfolding of 
V0 dimers arises: the antiparallel structure is native while the 
parallel form is not and the V region is involved in forming 
antiparallel FN dimers. The ER localized enzyme, protein 
disulfide isomerase (PDI), plays a key role in rearranging 
disulfide bonds to generate conformationally native struc- 
tures (Creighton et al., 1980; Freedman, 1984; Bulleid and 
Freedman, 1988).  The V region may be a binding site for 
such an enzyme and would thus allow rearrangement of par- 
allel bonds to form the preferred antiparallel type. The com- 
plete lack of a V region in either subunit would preclude the 
action of  this enzyme and leave the dimers in an unacceptable 
form.  Interestingly, PDI  has  recently been  shown  to  be 
highly homologous, if not identical, to another luminal ER 
protein, glycosylation site binding protein (GSBP), a protein 
that recognizes and binds to Asn-X-Thr/Ser  sites (Geetha- 
Habib et al., 1988).  In this report, GSBP was postulated to 
facilitate the interaction between these sites and oligosac- 
charyl transferase. On the other hand, PDI apparently func- 
tions as a homodimer (Freedman, 1984). So, although these 
two activities are very different, they seem to have one com- 
ponent in common. With the presence of a glycosylation site 
in the V region, GSBE and by analogy PDI, can presumably 
bind to sequences in or around this segment. We are cur- 
rently testing this hypothesis by coimmunoprecipitation ex- 
periments. 
An alternative hypothesis to explain our results is that the 
V region affects the association of FN monomers with each 
other. This segment may provide a FN binding site for an- 
tiparallel alignment of monomers (Ehrismann et al.,  1982) 
or a specific conformation required for subunit interactions 
independent of disulfide bonding (Homandberg et al., 1985; 
Robinson and Hermans, 1984).  Evidence exists for interac- 
tion between the COOH-terminal regions of FN monomers 
and between the COOH-terminal heparin domain and the 
NH2-terminal  fibrin domain (Homandberg and Erickson, 
1986).  Experiments to test the potential role of the V  seg- 
ment in FN self-association within the extracellular matrix 
are currently underway. 
Why do cells control the types of FN dimers that they se- 
crete in part by retaining V0 homodimers? Melanoma cells 
have been shown to use two sites within the V segment for 
cell attachment (Humphries et al., 1986, 1987; McCarthy et 
al.,  1986).  Furthermore, its proximity to the heparin and 
fibrin binding domains may suggest a role in modulating the 
interactions between FN and these molecules. Possibly con- 
struction of a functional extracellular matrix relies in part on 
the proportions of FN variants, and cells vary these at two 
levels,  splicing and secretion.  Different subunit combina- 
tions could then result in variable degrees of fibrillar branch- 
ing. The putative association of the V region with a counter- 
part on other FN subunits in the ER may mimic interactions 
that occur within the extracellular matrix. Alternatively, the 
solubility of FN may be changed by inclusion of the V re- 
gion, thus altering its properties once outside the cell. Only 
further experiments using this and other systems to test the 
activities of the V region, and of the other sites of alternative 
splicing, will determine the exact functions of variant FN 
subunits. 
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